Wakamoto Pharmaceutical: Report on Corporate Governance - July 4, 2024
Wakamoto Pharmaceutical: Extraordinary Report
Wakamoto Pharmaceutical: Internal Control Report - 129th Term (2023/04/01 - 2024/03/31)
Wakamoto Pharmaceutical: Confirmatory letter.
Wakamoto Pharmaceutical: Securities Report - 129th Fiscal Year (April 1, 2023 - March 31, 2024)
Wakamoto Pharmaceutical: (Correction/Numerical data correction) Partial correction of the 'March 2024 financial results briefing (Japan standard) (Non-consolidated)'.
WAKAMOTO PHARMACEUTICAL: 2024 Annual General Meeting of Shareholders Convocation Notice
WAKAMOTO PHARMACEUTICAL: Independent Officer Notification Form
WAKAMOTO PHARMACEUTICAL: Notice of Formulation of Mid-Term Management Plan
WAKAMOTO PHARMACEUTICAL: Notice regarding the opinions of the Board of Directors of the Company on shareholder proposals
WAKAMOTO PHARMACEUTICAL: Summary of financial results for the fiscal year ending 2024/3 [Japanese GAAP] (unconsolidated)
WAKAMOTO PHARMACEUTICAL: Corporate Governance Report 2024/05/15
WAKAMOTO PHARMACEUTICAL: Notice regarding revisions to earnings forecasts
Wakamoto Pharmaceutical: Notice regarding changes in officers
Wakamoto Pharmaceutical: Notice of election of candidates for outside directors
Wakamoto Pharmaceutical: Notice regarding revisions to dividend forecasts
Wakamoto Pharmaceutical: Notice Concerning the Recording of Profit from Sale of Investment Securities (Special Profit)
Wakamoto Pharmaceutical: Notice regarding revisions to earnings forecasts
Wakamoto Pharmaceutical: Quarterly Report - 129th Term 3rd Quarter (2023/10/01 - 2023/12/31)
Wakamoto Pharmaceutical: Confirmation
No Data